CeraVeAM BROAD SPECTRUM SUNSCREEN SPF 30 (Valeant Pharmaceuticals North America LLC)


Welcome to the PulseAid listing for the CeraVe drug offered from Valeant Pharmaceuticals North America LLC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Valeant Pharmaceuticals North America LLC
NON-PROPRIETARY NAME: Homosalate, Meradimate, Octinoxate, Zinc Oxide, and Octocrylene
SUBSTANCE NAME: HOMOSALATE; MERADIMATE; OCTINOXATE; OCTOCRYLENE; ZINC OXIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: LOTION
MARKETING CATEGORY NAME: OTC MONOGRAPH FINAL
START MARKETING DATE: 2015-06-15
END MARKETING DATE: 0000-00-00


CeraVe AM BROAD SPECTRUM SUNSCREEN SPF 30 HUMAN OTC DRUG Details:

Item DescriptionCeraVe AM BROAD SPECTRUM SUNSCREEN SPF 30 from Valeant Pharmaceuticals North America LLC
LABELER NAME: Valeant Pharmaceuticals North America LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 100; 50; 50; 20; 63(mg/mL; mg/mL; mg/mL; mg/mL; mg/mL)
START MARKETING DATE: 2015-06-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0187-1365_b1c8c075-6fa4-426d-b937-ce5cbe112898
PRODUCT NDC: 0187-1365
APPLICATION NUMBER: part352

Other HOMOSALATE; MERADIMATE; OCTINOXATE; OCTOCRYLENE; ZINC OXIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Valeant Pharmaceuticals North America LLCCeraVe